OrthoSpace - Acquired by Stryker (NYSE:SYE)

medical devices

About

OrthoSpace, founded in 2009 and based in Caesarea, Israel, is a medical technology company focused on orthopedic biodegradable balloon systems. Their flagship product, InSpace, is a biodegradable sub-acromial spacer designed to treat massive irreparable rotator cuff tears. This innovative solution aims to realign the natural biomechanics of the shoulder, reducing pain and improving function without extensive surgery. The InSpace system has been utilized in over 20,000 patients across 30 countries, showcasing its significant clinical history and global adoption. OrthoSpace was acquired by Stryker Corporation in March 2019, enhancing Stryker's portfolio in orthopedics and sports medicine. The acquisition was valued at $110 million upfront, with potential additional milestone payments. OrthoSpace targets orthopedic surgeons, sports medicine specialists, hospitals, and clinics worldwide, offering a minimally invasive treatment option that shortens surgery time and enhances patient recovery.

Technologies

CSC Corporate Domains Outlook Microsoft Office 365

Keywords

medical equipment manufacturing patient outcomes orthopaedics healthcare solutions surgical systems medical equipment and supplies manufacturing orthopedic and spine device manufacturing operational efficiency global operations biologics and regenerative medicine surgical equipment product innovation surgical and medical instrument manufacturing sustainable practices healthcare equipment and supplies manufacturing neurotechnology medical devices services r&d investment innovative medical devices neurotechnology and neurovascular devices medical training and education regulatory compliance digital health solutions clinical outcomes e-commerce quality assurance medical implants surgical navigation systems single-use device reprocessing

Location

7 Khalamish Street, Caesarea, Haifa District, Israel

Related Companies

Companies in the same industry